The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
![Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00680/article_deploy/html/images/pharmaceuticals-15-00680-ag-550.jpg)
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
![Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ... Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00503/asset/images/medium/jm0c00503_0024.gif)
Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...
![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![The Role of Peripheral Opioid Receptors in Triggering Heroin-induced Brain Hypoxia | Scientific Reports The Role of Peripheral Opioid Receptors in Triggering Heroin-induced Brain Hypoxia | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-57768-3/MediaObjects/41598_2020_57768_Fig1_HTML.png)
The Role of Peripheral Opioid Receptors in Triggering Heroin-induced Brain Hypoxia | Scientific Reports
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
![Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-019-0423-7/MediaObjects/41386_2019_423_Fig1_HTML.png)
Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior | Neuropsychopharmacology
![Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00892/article_deploy/html/images/pharmaceuticals-15-00892-g002.png)
Pharmaceuticals | Free Full-Text | Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects
![Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be0dab9f-5eed-4be6-942d-998c462787b6/tra12582-toc-0001-m.jpg?trick=1666529551600)
Dynamic lateral organization of opioid receptors (kappa, muwt and muN40D) in the plasma membrane at the nanoscale level - Rogacki - 2018 - Traffic - Wiley Online Library
![IJMS | Free Full-Text | Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes IJMS | Free Full-Text | Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes](https://www.mdpi.com/ijms/ijms-23-04885/article_deploy/html/images/ijms-23-04885-g001.png)
IJMS | Free Full-Text | Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes
![Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors](https://www.mdpi.com/molecules/molecules-27-00919/article_deploy/html/images/molecules-27-00919-ag.png)
Molecules | Free Full-Text | Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
![Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ... Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00503/asset/images/medium/jm0c00503_0001.gif)
Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects | Journal ...
![Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/cn200128x/asset/images/medium/cn-2011-00128x_0006.gif)